Coherus BioSciences
CHRS
$2.06
Share price
0.74%
Change (1 day)
-71.58%
Change (1 year)
Categories
Operating Margin for Coherus BioSciences (CHRS)
Operating Margin as of April 2024 (TTM): -129.89%
According to Coherus BioSciences 's latest financial reports and stock price the company's current Operating Margin is -129.89%. At the end of 2021 the company had an Operating Margin of -87.92%.
Operating Margin history for Coherus BioSciences from 2014 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -87.92% | -408.27% |
| 2020 | 28.52% | 9.46% |
| 2019 | 26.06% | |
| 2017 | -15,314.01% | 22682.15% |
| 2016 | -67.22% | -90.98% |
| 2015 | -745.44% | 165.98% |
| 2014 | -280.26% | -85.63% |
| 2013 | -1,949.65% | 12.13% |
| 2012 | -1,738.70% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 34.59% | -126.63% | 🇺🇸 USA |
 Repligen
RGEN | 27.34% | -121.05% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -84.50% | -34.94% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.